These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 166939)
41. Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Ohno S; Luka J; Lindahl T; Klein G Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1605-9. PubMed ID: 67603 [TBL] [Abstract][Full Text] [Related]
42. A simple method for the production of specific antiserum to the second nuclear antigen (EBNA-2) of Epstein-Barr virus (EBV). Dewhurst S; Volsky DJ J Immunol Methods; 1986 Mar; 87(2):283-7. PubMed ID: 3005420 [TBL] [Abstract][Full Text] [Related]
43. [Atypical profile problem in serological diagnosis of EBV]. Varıcı Balcı FK; Özbek ÖA; Sayıner AA Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068 [TBL] [Abstract][Full Text] [Related]
44. Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. Billings PB; Hoch SO; White PJ; Carson DA; Vaughan JH Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7104-8. PubMed ID: 6316343 [TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr virus nuclear antigen (EBNA)-positive cells in a lymph-node of a child with severe primary EBV infection. Lenoir G; De-The G; Virelizier JL; Griscelli C IARC Sci Publ (1971); 1978; (24 Pt 2):733-8. PubMed ID: 221396 [No Abstract] [Full Text] [Related]
46. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis. Sculley TB; Pope JH; Hazelton RA Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369 [TBL] [Abstract][Full Text] [Related]
48. Detection localization of Epstein-Barr virus-associated early antigens in single cells by autoradiography using 125I-labeled antibodies. (With 1 color plate). Moar MH; Siegert W; Klein G Intervirology; 1977; 8(4):226-39. PubMed ID: 194866 [TBL] [Abstract][Full Text] [Related]
49. Study of Epstein-Barr virus-determined nuclear antigen (EBNA) by chromatography on fixed cell nuclei. Hirsch I; Suchánková A; Závadová H; Vonka V Int J Cancer; 1978 Nov; 22(5):535-41. PubMed ID: 82540 [TBL] [Abstract][Full Text] [Related]
50. Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1. Inoue N; Kuranari J; Harada S; Nakajima H; Ohbayashi M; Nakamura Y; Miyasaka N; Ezawa K; Ban F; Yanagi K J Clin Microbiol; 1992 Jun; 30(6):1442-8. PubMed ID: 1320628 [TBL] [Abstract][Full Text] [Related]
51. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines. Luka J; Lindahl T; Klein G J Virol; 1978 Sep; 27(3):604-11. PubMed ID: 212583 [TBL] [Abstract][Full Text] [Related]
52. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups. Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990 [TBL] [Abstract][Full Text] [Related]
53. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726 [TBL] [Abstract][Full Text] [Related]
54. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Dillner J; Sternås L; Kallin B; Alexander H; Ehlin-Henriksson B; Jörnvall H; Klein G; Lerner R Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4652-6. PubMed ID: 6205400 [TBL] [Abstract][Full Text] [Related]
55. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients. Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981 [No Abstract] [Full Text] [Related]
56. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related]
57. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
58. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343 [TBL] [Abstract][Full Text] [Related]